Skip to search formSkip to main contentSkip to account menu

EMD 525797

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Anti-alphaVbeta3 Monoclonal Antibody EMD 525797DI17E6

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases…
231 Background: EMD 525797 is a humanized monoclonal IgG2 antibody specifically targeting αv integrins involved in tumor… 
2012
2012
Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases…
231 Background: EMD 525797 is a humanized monoclonal IgG2 antibody specifically targeting αv integrins involved in tumor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)